Navigation Links
Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
Date:7/10/2008

WASHINGTON, July 10 /PRNewswire-USNewswire/ -- The Association of Clinical Research Organizations (ACRO), which represents the clinical outsourcing industry to regulators, biopharmaceutical clients, policy makers and the public in the U.S. and worldwide, recently announced the election of Dr. Derek Winstanly as Chair-Elect of the association.

Derek Winstanly, MBChB, Executive Vice President of Strategic Business Partnerships for Quintiles Transnational, was appointed the 2008 Chair-Elect in June. Dr. Winstanly is a respected leader of the clinical research organization (CRO) industry, having held various global leadership positions within Quintiles since joining the company in 1999. In his current role, he works with senior biopharmaceutical executives to provide long-term strategic solutions, and is responsible for the Office of the Chief Medical Officer as well as the ethics and quality assurance functions of the company.

"I congratulate Dr. Winstanly on his appointment as Chair-Elect of ACRO," said David Spaight, ACRO Chair and President of MDS Pharma Services. "His experience and insight will enhance the association's efforts to demonstrate the important contributions that CROs make to the clinical research enterprise."

"I am pleased to join the leadership of ACRO at a time of extraordinary growth for our industry," added Dr. Winstanly. "I look forward to driving the association's efforts to increase public understanding about the vital role CROs play in the conduct of safe and high-quality clinical studies to accelerate the development of new medical treatments."

About ACRO

The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association provides an active voice for the CRO industry, which provides specialized services that are integral to the development of drugs, biologics and medical devices. ACRO helps its members improve the quality, efficiency and safety of biomedical research. For more information, please visit HYPERLINK "http://www.acrohealth.org/" http://www.acrohealth.org.


'/>"/>
SOURCE Association of Clinical Research Organizations
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
2. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
3. Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association
4. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
5. Grocery Manufacturers Association: Study Signals Progress in Battle Against Obesity
6. CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting
7. Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
8. Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
9. Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting
10. Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidones Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events
11. Association of Clinical Research Organizations (ACRO) to Help Lead Clinical Trials Transformation Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , Jan 20, 2017 Research and ... Laboratory Testing Market By Type of Test (Tumor, Clinical Chemistry, ... By Type of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast ... ... destination for healthcare services, market segments, especially clinical lab testing, ...
(Date:1/21/2017)... 2017 ARMO BioSciences, Inc., a late-stage immuno-oncology ... Company,s lead investigational immuno-oncology drug AM0010 (PEGylated Interleukin-10) at ... Society of Clinical Oncology (ASCO), taking place January 19-21, ... "AM0010 induces the expansion of novel ... cells in the blood and tumors of our patients," ...
(Date:1/21/2017)... -- Faruqi & Faruqi, LLP, a leading national securities law firm, ... KMPH ) of the federal securities class action ... and underwriters of the Company,s April 16, 2015 Initial Public ... The lawsuit has been filed in the ... County on behalf of all those who acquired ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... January 23, 2017 , ... Moisture measurement is ... right method is paramount to success. Selecting an inappropriate measurement method can cause ... persons use the same equipment. Rare or expensive substances are wasted and production ...
(Date:1/23/2017)... Georgia (PRWEB) , ... January 23, 2017 , ... ... in providing high-quality general gynecological care and gynecological services for women ... providing personalized care for a wide variety of reproductive services from routine health ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Some Infallible Characteristics of ... Father. “Some Infallible Characteristics of Christ” is the creation of published author, Rev. Dr. ... Baptist Church for thirteen years, a preacher for over nineteen, a pastor for over ...
(Date:1/22/2017)... ... 2017 , ... Medical lab testing through hospitals and other traditional ... test will take days to arrive to the end customer, having to travel through ... their lab tests, bypassing the cost and delay of traditional means. Now all employees ...
(Date:1/21/2017)... ... 21, 2017 , ... Phytocéane invites you to take an exotic ... the world with ZANZIBAR SHOWER GEL. Inspired by the beauty of Zanzibar, a Tanzanian ... and moisturizing vegetal coral to create this gentle, crystal-clear shower gel to cleanse the ...
Breaking Medicine News(10 mins):